10 results
10-K
2020 FY
BVS
Bioventus Inc - Ordinary Shares
26 Mar 21
Annual report
4:13pm
the body of clinical evidence supporting our products, we continue to look for and execute on opportunities to innovate in our BGS portfolio. To meet
424B4
BVS
Bioventus Inc - Ordinary Shares
12 Feb 21
Prospectus supplement with pricing info
6:29am
our products, we continue to look for and execute on opportunities to innovate in our BGS portfolio. To meet growing market demand and evolving surgical
DRS/A
s06s laa3d2ey
10 Nov 20
Draft registration statement (amended)
12:00am
DRS
0pt6oz9azfvqz
6 Oct 20
Draft registration statement
12:00am
- Prev
- 1
- Next